siRNA Genome Screening Approaches to Therapeutic Drug Repositioning
Bridging high-throughput screening (HTS) with RNA interference (RNAi) has allowed for rapid discovery of the molecular basis of many diseases, and identification of potential pathways for developing safe and effective treatments. These features have identified new host gene targets for existing drug...
Main Authors: | Perwitasari, Olivia, Bakre, Abhijeet, Tompkins, S. Mark, Tripp, Ralph A. |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816683/ |
Similar Items
-
Therapeutic siRNA: Principles, Challenges, and Strategies
by: Gavrilov, Kseniya, et al.
Published: (2012) -
Therapeutic siRNA silencing in inflammatory monocytes
by: Leuschner, Florian, et al.
Published: (2011) -
Therapeutic siRNA for drug-resistant HER2-positive breast cancer
by: Gu, Shenda, et al.
Published: (2016) -
Preclinical Development of siRNA Therapeutics for AL Amyloidosis
by: Hovey, Beth M., et al.
Published: (2011) -
Design of siRNA Therapeutics from the Molecular Scale
by: Angart, Phillip, et al.
Published: (2013)